A field-ready LOI framework built for insurance book-of-business deals — covering earnout structures, carrier appointment continuity, client retention milestones, and producer retention clauses specific to life and health agencies.
A Letter of Intent (LOI) for a life and health insurance agency acquisition is far more nuanced than a standard business LOI. Because agency value is tied almost entirely to the quality and stickiness of the book of business — not physical assets or equipment — your LOI must address the unique risks of this sector head-on. Key deal terms must account for client attrition post-close, carrier appointment transferability, producer retention, and the distinction between commission revenue that will renew versus revenue tied to the departing owner's personal relationships. In the lower middle market, most life and health agency deals fall in the $1M–$5M revenue range and trade at 2.5x–4.5x recurring annual commissions, with purchase price adjustments frequently tied to book retention measured at 12 and 24 months post-close. This guide walks through every major LOI section, provides example language tailored to insurance agency transactions, and highlights the negotiation dynamics specific to this industry.
Find Insurance Agency (Life & Health) Businesses to AcquireParties and Transaction Overview
Identifies the buyer and seller entities, the target agency, and the general nature of the transaction — whether it is structured as an asset purchase (acquiring the book of business, client relationships, and carrier appointments) or a stock purchase (acquiring the operating entity). Most life and health agency acquisitions are structured as asset purchases to isolate the buyer from historical E&O exposure and regulatory liabilities.
Example Language
This Letter of Intent is entered into as of [Date] by and between [Buyer Entity Name] ('Buyer') and [Seller Entity Name] ('Seller'), with respect to Buyer's proposed acquisition of substantially all assets of [Agency Name], including but not limited to the book of business, client relationships, carrier appointments, producer agreements, CRM data, and goodwill associated with the agency's life, health, Medicare Advantage, and group benefits operations. The proposed transaction is intended to be structured as an asset purchase. The parties acknowledge this LOI is non-binding except as to the provisions governing exclusivity, confidentiality, and governing law.
💡 Sellers often prefer a stock sale for tax efficiency, while buyers strongly prefer an asset purchase to avoid inheriting E&O claims, regulatory violations, or undisclosed liabilities. Clarify this early — it affects price, structure, and how carrier appointments will be handled. If the seller insists on a stock sale, the buyer should price in a larger indemnification escrow and conduct deeper E&O diligence.
Purchase Price and Valuation Basis
States the proposed total purchase price, the valuation methodology used, and how the price is calculated relative to the agency's trailing twelve-month or average three-year recurring commission revenue. Life and health agency deals are typically valued on a multiple of recurring commissions, not EBITDA, because of the predictable renewal income stream.
Example Language
Subject to the completion of due diligence and the conditions set forth herein, Buyer proposes a total purchase price of approximately $[X,XXX,000] ('Purchase Price'), representing approximately [3.0x–4.0x] the Agency's trailing twelve-month recurring annual commissions of $[XXX,000] as reported for the period ending [Date]. The Purchase Price excludes any contingent earnout amounts described in Section [X]. Recurring commissions are defined as renewal commissions received from existing in-force policies, excluding one-time placement fees and any non-recurring revenue sources. Final Purchase Price will be subject to adjustment based on findings from the book-of-business audit conducted during due diligence.
💡 Sellers will often include contingent bonus commissions and one-time placement fees in their revenue figures to inflate the valuation base. Buyers should define 'recurring commissions' precisely in the LOI — limiting it to verified renewal income from in-force policies. Request a carrier-by-carrier commission statement for the trailing 24 months to validate the number before signing.
Deal Structure and Payment Terms
Outlines how the purchase price will be funded and paid, including the upfront cash component, any SBA financing, seller financing, and earnout provisions tied to post-close book retention. The split between upfront cash and earnout is one of the most heavily negotiated elements in insurance agency deals.
Example Language
The proposed Purchase Price shall be funded and paid as follows: (i) $[XXX,000] in cash at closing, funded in part through an SBA 7(a) loan for which Buyer is seeking pre-approval; (ii) a seller note of $[XX,000] representing approximately [10–15]% of the Purchase Price, to be repaid over [24] months at [6]% per annum, which note shall be on standby during the SBA loan period; and (iii) an earnout of up to $[XXX,000] payable in two installments — 50% at the 12-month anniversary of closing and 50% at the 24-month anniversary — contingent upon the Agency's book of business retaining no less than [85]% of trailing twelve-month recurring commissions as measured on each anniversary date, calculated on a policy-count and commission-weighted basis.
💡 Sellers want maximum upfront cash; buyers want maximum earnout exposure to protect against client attrition. A reasonable market structure for a well-documented agency with strong persistency is 70–80% upfront at close and 20–30% in earnout. If the seller's book is heavily owner-centric, buyers should push for a larger earnout percentage and a longer measurement window. Tie the earnout to commission dollars retained — not just policy count — since some clients may downgrade coverage rather than cancel outright.
Earnout Mechanics and Retention Measurement
Specifies exactly how client retention will be measured, what counts as an attrited policy, how disputes are resolved, and what obligations the seller has during the earnout period to support client transition. This is the most operationally complex section of an insurance agency LOI and deserves specific, detailed language.
Example Language
For purposes of calculating earnout payments, 'Retained Commissions' shall mean the aggregate recurring commissions received by Buyer during the applicable measurement period from policies that were active and in-force as of the closing date. Policies that lapse, are cancelled by the client, or are not renewed due to carrier non-renewal shall be treated as attrited for purposes of this calculation. Policies lost due to Buyer's affirmative decision to exit a carrier relationship or product line shall be excluded from the attrition calculation. Seller agrees to provide transition assistance during the earnout period including client introduction calls, co-servicing of top 50 accounts by commission volume, and attendance at no fewer than [X] client review meetings per quarter during the first 12 months post-close, as further detailed in a Transition Services Agreement to be executed at closing.
💡 Sellers will argue that any client attrition after close is the buyer's fault. Buyers should negotiate that the seller bears responsibility for attrition directly traceable to client relationships the seller held personally. Include language that tolls the retention measurement if Buyer changes service protocols, carrier relationships, or pricing in ways outside normal course of business.
Book-of-Business Due Diligence Access
Grants the buyer access to policy-level book data, carrier commission statements, CRM records, and client files needed to verify the quality and composition of the book before closing. This section should specify what data will be provided and the format required.
Example Language
Within [10] business days of the execution of this LOI, Seller shall provide Buyer with: (i) a complete policy-level book report including insured names (or anonymized identifiers prior to NDA execution), policy numbers, carriers, product lines, annual premiums, agency commissions, effective dates, and last renewal dates; (ii) carrier commission statements for the trailing 24 months from all carriers with active appointments; (iii) lapse and non-renewal reports for the trailing 36 months by carrier and product; (iv) a list of the top 25 accounts by annual commission volume with tenure and relationship owner noted; and (v) current CRM export in a mutually agreed format. Seller shall also provide access to E&O insurance certificates and a 5-year claims history report.
💡 Many smaller agency owners maintain informal records or rely entirely on carrier portals for commission tracking. If the seller cannot produce a clean policy-level export within the due diligence period, treat this as a significant red flag. Consider building a specific closing condition requiring data delivery in an agreed format — incomplete or unverifiable books are the most common source of post-close disputes in insurance agency acquisitions.
Carrier Appointment Continuity
Addresses the process for transferring or maintaining carrier appointments, the risk that certain carriers may not approve the buyer as a successor agent, and any bridging arrangements needed to ensure commission continuity during the transition period.
Example Language
Buyer and Seller shall cooperate in good faith to obtain transfer or successor appointment approvals from all carriers with active appointments as of the closing date, including but not limited to [list key carriers]. Seller shall provide written notice to each carrier of the proposed transaction promptly following the execution of this LOI and shall use commercially reasonable efforts to facilitate Buyer's appointment with each carrier prior to closing. To the extent any carrier appointment cannot be transferred prior to closing, the parties shall enter into a sub-agency or commission flow arrangement, subject to carrier approval and applicable state insurance regulations, to ensure uninterrupted commission payments to Buyer post-close. Closing shall be conditioned on Buyer receiving appointment approvals from carriers representing no less than [80]% of trailing twelve-month commissions.
💡 Carrier appointment transferability is one of the most underestimated risks in insurance agency deals. Some carriers — particularly Medicare Advantage plans — have strict approval processes and may not automatically approve a new owner. Build a closing condition that requires appointment approvals from your most critical carriers before funds are released. If a key carrier denies appointment, you need the contractual right to renegotiate price or walk away.
Licensed Staff and Producer Retention
Identifies key licensed producers and staff whose retention is material to the value of the book, outlines any employment or independent contractor offers the buyer intends to make, and addresses non-solicitation obligations of the seller post-close.
Example Language
Buyer acknowledges that the continued employment of the following licensed producers is material to the transaction: [Name/Title], [Name/Title] (collectively, 'Key Producers'). As a condition to closing, Buyer intends to extend employment or independent contractor offers to Key Producers on terms no less favorable than their current compensation arrangements. Seller agrees not to solicit, encourage, or assist any Key Producer or licensed staff member to terminate their relationship with Buyer for a period of [36] months following the closing date. Seller further agrees to execute a non-solicitation agreement at closing prohibiting Seller from directly or indirectly soliciting any client included in the transferred book of business for a period of [3–5] years.
💡 If the seller is the primary relationship holder and will not be staying post-close, client retention risk is dramatically elevated. In that scenario, push for a longer transition period (12–18 months), a structured handoff plan for every top-25 account, and earnout language that captures this risk. Non-solicitation agreements must be tailored to state law — some states, particularly California, impose strict limits on enforceability.
Exclusivity Period
Grants the buyer an exclusive negotiation period during which the seller agrees not to solicit or entertain competing offers from other buyers. This is one of the binding provisions of the LOI.
Example Language
In consideration of Buyer's commitment to proceed with due diligence and incur related costs, Seller agrees to negotiate exclusively with Buyer for a period of [60] days from the date of this LOI ('Exclusivity Period'). During the Exclusivity Period, Seller shall not, directly or indirectly, solicit, encourage, or engage in discussions with any other party regarding the sale of the Agency, its book of business, or any material portion of its assets. The Exclusivity Period may be extended by mutual written agreement of the parties.
💡 60 days is standard for an insurance agency deal given the complexity of book-of-business diligence and carrier appointment verification. If the seller is receiving multiple offers or working with a broker, they may push for a shorter window (30–45 days). Buyers should resist shortening exclusivity — carrier appointment diligence alone can take 3–4 weeks to complete properly.
Conditions to Closing
Lists the material conditions that must be satisfied before the buyer is obligated to close, including financing, due diligence completion, carrier appointment approvals, staff retention, and regulatory approvals.
Example Language
Buyer's obligation to close is conditioned upon, among other things: (i) satisfactory completion of due diligence, including a book-of-business audit confirming recurring commissions within [5]% of the amounts represented by Seller; (ii) receipt of SBA loan approval and commitment letter; (iii) execution of carrier appointment or sub-agency agreements with carriers representing no less than [80]% of trailing twelve-month commissions; (iv) execution of employment or contractor agreements with Key Producers; (v) delivery by Seller of representations and warranties in form and substance satisfactory to Buyer regarding E&O claims history, regulatory compliance, and accuracy of book data; and (vi) receipt of all required regulatory approvals and state insurance department notifications.
💡 Include a book-of-business accuracy condition explicitly — this gives you the right to reprice or walk if due diligence reveals the commissions are materially lower than represented. Sellers will try to limit your walk-away rights; frame conditions as objective and measurable (e.g., percentage thresholds) rather than subjective to minimize disputes.
Confidentiality
Binds both parties to keep the existence and terms of the proposed transaction confidential, which is particularly important in the insurance industry where disclosure could trigger client concern, carrier scrutiny, or staff departures before close.
Example Language
Each party agrees to keep the existence, terms, and subject matter of this LOI and the proposed transaction strictly confidential and shall not disclose any such information to any third party without the prior written consent of the other party, except to each party's legal counsel, financial advisors, lenders, and as required by law. Seller specifically acknowledges that premature disclosure of the proposed transaction to clients, carrier representatives, or agency staff could materially harm the value of the book of business and agrees to limit internal disclosure to those with a strict need to know. This confidentiality obligation shall survive any termination of this LOI for a period of [24] months.
💡 Confidentiality is especially critical in insurance agency deals. If word leaks to clients that the agency is being sold — particularly in Medicare or group benefits books where switching is easy — you can see meaningful pre-close attrition that undermines the entire deal. Establish a mutual communication protocol before any staff or carrier notifications occur.
Recurring Commission Definition and Validation
The single most important economic term. Insist on a precise, written definition of 'recurring commissions' that excludes placement fees, contingent bonuses, and non-renewable income. Validate the number against actual carrier commission statements for the trailing 24 months — not the seller's internal P&L.
Earnout Retention Threshold and Measurement Methodology
Negotiate the minimum retention percentage that triggers each earnout installment and whether it is measured on commission dollars, policy count, or both. Commission-weighted measurement is more buyer-favorable. A typical threshold is 85–90% retention; below that, the earnout is reduced on a pro-rata basis rather than eliminated entirely.
Carrier Appointment Closing Condition
Define which carriers are 'critical' and what minimum appointment coverage (by commission percentage) must be confirmed before closing is required. Buyers should not close without confirmed appointments from carriers representing at least 75–80% of commissions — especially Medicare Advantage and major group health carriers.
Seller Transition and Non-Solicitation Period
Negotiate the length and scope of the seller's active involvement post-close — both the transition assistance period (typically 6–18 months) and the non-solicitation restriction (typically 3–5 years). A seller who was the primary relationship holder should have a longer, more structured transition obligation tied to the earnout.
E&O Indemnification Tail and Escrow
Require the seller to maintain an E&O insurance tail policy for the period of the statute of limitations on potential claims arising from pre-close agency activities. In an asset purchase, negotiate a specific indemnification escrow (typically 10–15% of purchase price held for 12–24 months) to cover pre-close E&O claims, regulatory violations, or book-of-business misrepresentation.
Find Insurance Agency (Life & Health) Businesses to Acquire
Enough information to write a strong LOI on day one — free to join.
Most independent life and health agencies in the $1M–$5M revenue range trade at 2.5x–4.5x trailing recurring annual commissions, with the multiple driven by book quality rather than size. Agencies with persistency rates above 90%, diversified carrier relationships, documented CRM systems, and a team of licensed producers (not just an owner-centric book) will command multiples at the higher end. Medicare-heavy books or groups with sticky employer benefits relationships often receive premium multiples due to predictable renewal cycles. Conversely, books with high owner dependency, thin documentation, or concentration in a single carrier or product line typically price at 2.5x–3.0x.
Most insurance agency earnouts are paid in two installments — one at the 12-month anniversary and one at the 24-month anniversary of closing — contingent on the book retaining a defined percentage of trailing recurring commissions, typically 85–90%. If retention falls below the threshold, the earnout is reduced pro-rata rather than forfeited entirely, which is fairer to both parties. The earnout typically represents 20–30% of the total purchase price for a well-documented agency with a clear transition plan, and up to 35–40% for an owner-centric book where attrition risk is elevated. Sellers should push to define exactly what events (buyer-caused carrier exits, service changes) are excluded from the attrition calculation.
Yes. Life and health insurance agency acquisitions are generally SBA 7(a) eligible, and SBA financing is one of the most common funding structures in this market. The SBA will lend on the goodwill value of the book of business, which is the primary asset being acquired. Lenders with insurance industry experience will typically require the seller to carry a standby seller note representing 10–15% of the purchase price, which cannot be repaid until the SBA loan is satisfied or until the SBA grants a waiver. Pre-qualification before submitting your LOI significantly strengthens your offer in a competitive situation.
Carrier appointments do not automatically transfer to the buyer — each carrier must approve the new owner and may require re-appointment applications, background checks, and in some cases a waiting period. This is particularly true for Medicare Advantage plans, which have strict CMS-regulated contracting requirements. In the interim period, some transactions use a sub-agency or commission flow arrangement where the seller entity continues to receive commissions and passes them through to the buyer — subject to carrier approval and state insurance law. Your LOI should make receipt of appointments from carriers representing a defined percentage of commissions a hard condition to closing.
This is the most significant risk in life and health agency acquisitions. The primary protections are: (1) a longer, more structured transition period — ideally 12–18 months with specific client introduction milestones and co-servicing obligations documented in a Transition Services Agreement; (2) a larger earnout component (30–40% of price) measured over 24 months; (3) a strong non-solicitation agreement prohibiting the seller from re-entering the market in the agency's geographic and carrier footprint; and (4) a client communication strategy developed jointly before close that introduces the buyer to top accounts with the seller's personal endorsement. Never close on an owner-centric book without a written, specific transition plan.
Errors and omissions (E&O) liability from pre-close activities can follow the seller's entity even in an asset purchase, but buyers should conduct a thorough E&O history review as part of due diligence. Request a 5-year claims history from the seller's E&O carrier and verify that coverage is current with no lapses. In the LOI, establish that the seller will maintain an E&O tail policy post-close for the applicable statute of limitations period and negotiate an indemnification escrow of 10–15% of purchase price to cover pre-close claims. Some buyers also require the seller to represent and warrant that there are no pending or threatened E&O claims, regulatory investigations, or DOI complaints as a closing condition.
More Insurance Agency (Life & Health) Guides
More LOI Templates
Get enough diligence data to write a confident LOI from day one.
Create your free accountNo credit card required
For Buyers
For Sellers